AU2001224716A1 - A medicinal aerosol formulation - Google Patents

A medicinal aerosol formulation

Info

Publication number
AU2001224716A1
AU2001224716A1 AU2001224716A AU2001224716A AU2001224716A1 AU 2001224716 A1 AU2001224716 A1 AU 2001224716A1 AU 2001224716 A AU2001224716 A AU 2001224716A AU 2001224716 A AU2001224716 A AU 2001224716A AU 2001224716 A1 AU2001224716 A1 AU 2001224716A1
Authority
AU
Australia
Prior art keywords
aerosol formulation
medicinal aerosol
medicinal
formulation
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001224716A
Other versions
AU2001224716B2 (en
Inventor
Akwete L. Adjei
Anthony J. Cutie
Frederick A. Sexton
John Z. Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeropharm Technology LLC
Original Assignee
Aeropharm Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/702,939 external-priority patent/US6540983B1/en
Application filed by Aeropharm Technology LLC filed Critical Aeropharm Technology LLC
Publication of AU2001224716A1 publication Critical patent/AU2001224716A1/en
Application granted granted Critical
Publication of AU2001224716B2 publication Critical patent/AU2001224716B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001224716A 2000-01-25 2001-01-02 A medicinal aerosol formulation Ceased AU2001224716B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17792200P 2000-01-25 2000-01-25
US60/177,922 2000-01-25
US09/702,939 2000-10-31
US09/702,939 US6540983B1 (en) 2000-01-25 2000-10-31 Medical aerosol formulation
PCT/US2001/000028 WO2001054741A1 (en) 2000-01-25 2001-01-02 A medicinal aerosol formulation

Publications (2)

Publication Number Publication Date
AU2001224716A1 true AU2001224716A1 (en) 2001-10-18
AU2001224716B2 AU2001224716B2 (en) 2005-10-13

Family

ID=26873780

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2471601A Pending AU2471601A (en) 2000-01-25 2001-01-02 A medicinal aerosol formulation
AU2001224716A Ceased AU2001224716B2 (en) 2000-01-25 2001-01-02 A medicinal aerosol formulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2471601A Pending AU2471601A (en) 2000-01-25 2001-01-02 A medicinal aerosol formulation

Country Status (11)

Country Link
US (1) US6540983B1 (en)
EP (1) EP1289573B1 (en)
JP (1) JP2003520829A (en)
CN (1) CN1235641C (en)
AT (1) ATE433317T1 (en)
AU (2) AU2471601A (en)
CA (1) CA2396785C (en)
DE (1) DE60138948D1 (en)
ES (1) ES2328556T3 (en)
MX (1) MXPA02007188A (en)
WO (1) WO2001054741A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE385193T1 (en) 2002-03-20 2008-02-15 Mannkind Corp INHALATION DEVICE
US20080260838A1 (en) * 2003-08-01 2008-10-23 Mannkind Corporation Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK1791542T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for pharmaceutical delivery
WO2007017482A1 (en) * 2005-08-08 2007-02-15 Novartis Ag Insulated canister for metered dose inhalers
BRPI0615819B8 (en) 2005-09-14 2021-05-25 Mannkind Corp process for preparing a drug delivery composition comprising an active agent and a crystalline fumaryl diketopiperazine microparticle.
CN101389348A (en) 2006-02-22 2009-03-18 曼金德公司 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US7819800B2 (en) * 2006-12-15 2010-10-26 Ethicon Endo-Surgery, Inc. Fully automated iris seal for hand assisted laparoscopic surgical procedures
US8197404B2 (en) * 2006-12-15 2012-06-12 Ethicon Endo-Surgery, Inc. Handoscopy interwoven layered seal laparoscopic disk
US7967748B2 (en) * 2006-12-15 2011-06-28 Ethicon Endo-Surgery, Inc. Resiliently supported seal cap for hand assisted laparoscopic surgical procedures
EP2954893A1 (en) * 2007-10-24 2015-12-16 MannKind Corporation An inhalable dry powder formulation comprising glp-1 for use in the treatment of hyperglycemia and diabetes
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
EP3272379A1 (en) 2008-02-07 2018-01-24 The University of Washington Circumferential aerosol device
CA3086027C (en) 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MX2010014240A (en) 2008-06-20 2011-03-25 Mankind Corp An interactive apparatus and method for real-time profiling of inhalation efforts.
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (en) 2009-03-11 2013-12-16 Mannkind Corp DEVICE, SYSTEM AND PROCEDURE FOR MEASURING RESISTANCE IN AN INHALATOR
WO2010144789A2 (en) 2009-06-12 2010-12-16 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
KR20130117755A (en) 2010-06-21 2013-10-28 맨카인드 코포레이션 Dry powder drug delivery system and methods
WO2012119153A2 (en) 2011-03-03 2012-09-07 Impel Neuropharma Inc. Nasal drug delivery device
TWI399202B (en) 2011-03-17 2013-06-21 Intech Biopharm Ltd The preparation for formulation composition and manufacturing processes of metered dose inhalers treated respiratory diseases
WO2012135765A2 (en) 2011-04-01 2012-10-04 Mannkind Corporation Blister package for pharmaceutical cartridges
CA2835208C (en) 2011-05-09 2019-08-20 Impel Neuropharma, Inc. Nozzles for nasal drug delivery
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (en) 2011-10-24 2014-09-22 Mannkid Corp Methods and compositions for treating pain.
CN104619369B (en) 2012-07-12 2018-01-30 曼金德公司 Dry-powder medicament induction system and method
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
EP2968371A4 (en) 2013-03-12 2017-04-12 The Board of Trustees of the Leland Stanford Junior University Modulation of cellular dna repair activity to intercept malignancy
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
CA2909954C (en) 2013-04-28 2021-03-23 Impel Neuropharma, Inc. Medical unit dose container
JP6491658B2 (en) 2013-07-18 2019-03-27 マンカインド コーポレイション Thermally stable dry powder pharmaceutical composition and method
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN108704201A (en) * 2015-05-16 2018-10-26 苏州汉方医药有限公司 The medicine box being made of manual microactuator suspension particle generator and compound astragalus membranaceus
NZ741171A (en) 2015-09-10 2022-01-28 Impel Neuropharma Inc In-line nasal delivery device
WO2019104205A1 (en) 2017-11-21 2019-05-31 Impel Neuropharma, Inc. Intranasal device with dip tube
JP2021503988A (en) 2017-11-21 2021-02-15 インペル ニューロファーマ インコーポレイテッド Intranasal device with inlet interface
BR112020013750A8 (en) 2018-01-05 2022-10-18 Impel Neuropharma Inc INTRANASAL DISPENSE OF OLANZAPINE BY PRECISION OLFATIVE DEVICE
CA3088942C (en) 2018-01-05 2023-01-03 Impel Neuropharma, Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
CN112955134A (en) 2018-07-19 2021-06-11 英倍尔药业股份有限公司 Respiratory delivery of levodopa and dopa decarboxylase inhibitors for the treatment of parkinson's disease
BR112021013244A8 (en) 2019-01-03 2022-10-18 Impel Neuropharma Inc NASAL DRUG DELIVERY DEVICE
JP2022532259A (en) 2019-05-17 2022-07-13 インペル ファーマシューティカルズ インコーポレイテッド Disposable intranasal delivery device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2348264A1 (en) 1976-04-16 1977-11-10 Montedison Spa COMPOSITION OF PROPELLANT GASES FOR AEROSOLS
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5011678A (en) 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
JPH05508616A (en) 1989-02-23 1993-12-02 ローヌー プーラン ローラー インターナショナル(ホウルディングス)インコーポレイテッド therapeutic aerosol
HU222249B1 (en) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Process for producing amyline antagonistic peptide derivatives and pharmaceutical preparatives containing them
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
GB9202519D0 (en) 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JPH08509465A (en) * 1993-01-29 1996-10-08 マイリス メディカル コーポレーション Intrapulmonary delivery of hormones
US5743250A (en) * 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
EP1462096B1 (en) * 1994-03-07 2008-12-10 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
WO1996019198A1 (en) 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
CO5090908A1 (en) * 1998-08-28 2001-10-30 Lilly Co Eli PROCEDURE FOR MANAGING INSULINOTROPIC PEPTIDES

Similar Documents

Publication Publication Date Title
AU2001224716A1 (en) A medicinal aerosol formulation
AU2001226233A1 (en) A medicinal aerosol formulation
AU2753001A (en) A medicinal aerosol formulation
EP1296723A4 (en) A medicinal aerosol formulation
AU4519001A (en) A medicinal aerosol formulation
AU2002218250A1 (en) Medicament dispenser
AU6310000A (en) Aerosol formulations
AU1131102A (en) Medicinal aerosol formulations
AU2002223562A1 (en) Medicament dispenser
AUPR054400A0 (en) A castor
AU2001227535A1 (en) A core formulation
AU2001227532A1 (en) A core formulation
AU2001224718A1 (en) A medicinal aerosol formulation
AU2623401A (en) A medicinal aerosol formulation
AUPR000900A0 (en) A berley dispenser
AU2001259318A1 (en) A medicinal aerosol formulation
AU1141101A (en) Pharmaceutical aerosol formulations comprising s-salmeterol
HUP0600143A2 (en) A stable pharmaceutical formulation comprising torsemide modification ii
AU2001247123A1 (en) A medicinal aerosol formulation
AU2001227531A1 (en) A medicinal aerosol formulation
EP1292283A4 (en) A medicinal aerosol formulation
AU2001272718A1 (en) Medicaments
AU2002215902A1 (en) Medicament dispenser
GB0014849D0 (en) Pharmaceutical aerosol formulation
AU2002223437A1 (en) Medicament dispenser